Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q1 2022 Results - Earnings Call Transcript

May 11, 2022 9:13 PM ETCytek Biosciences, Inc. (CTKB)
SA Transcripts profile picture
SA Transcripts

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2022 Earnings Conference Call May 11, 2022 5:00 PM ET

Company Participants

Paul Goodson - Head, IR

Wenbin Jiang - President, CEO & Chairman

Patrik Jeanmonod - CFO

Conference Call Participants

Max Masucci - Cowen and Company

Matthew Sykes - Goldman Sachs Group

David Westenberg - Piper Sandler & Co.

Tejas Savant - Morgan Stanley


Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2022 Earnings Conference Call. [Operator Instructions]. As a reminder, today's program may be recorded. And now I'd like to introduce your host for today's program, Paul Goodson, Investor Relations. Please go ahead, sir.

Paul Goodson

Thank you, operator. Earlier today, Cytek Biosciences released financial results for the quarter ended March 31, 2022. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to Joining me today from Cytek are Wenbin Jiang, CEO; and Patrik Jeanmonod, Chief Financial Officer.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding Cytek's business plans, strategies, opportunities and financial projections. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release Cytek issued today and in Cytek filings with the SEC.

This call will also include a discussion of certain financial measures that are not calculated in accordance with generally accepted accounting principles. Reconciliation to the most directly comparable GAAP financial measure may be found in today's earnings release submitted to the SEC. Except as required by law, Cytek disclaims any

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.